HighTower Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-212,260
| Closed | -$266K | – | 3284 |
|
|
2022
Q1 | $266K | Hold |
212,260
| – | – | ﹤0.01% | 2592 |
|
|
2021
Q4 | $246K | Hold |
212,260
| – | – | ﹤0.01% | 2593 |
|
|
2021
Q3 | $408K | Sell |
212,260
-10
| -0% | -$19 | ﹤0.01% | 2198 |
|
|
2021
Q2 | $496K | Buy |
212,270
+2,210
| +1% | +$5.16K | ﹤0.01% | 2053 |
|
|
2021
Q1 | $569K | Hold |
210,060
| – | – | ﹤0.01% | 1896 |
|
|
2020
Q4 | $508K | Hold |
210,060
| – | – | ﹤0.01% | 1619 |
|
|
2020
Q3 | $481K | Buy |
210,060
+41,575
| +25% | +$95.2K | ﹤0.01% | 1580 |
|
|
2020
Q2 | $387K | Buy |
168,485
+1,250
| +0.7% | +$2.87K | ﹤0.01% | 1574 |
|
|
2020
Q1 | $287K | Buy |
167,235
+3,000
| +2% | +$5.15K | ﹤0.01% | 1580 |
|
|
2019
Q4 | $339K | Buy |
164,235
+1,000
| +0.6% | +$2.06K | ﹤0.01% | 1637 |
|
|
2019
Q3 | $474K | Sell |
163,235
-6,500
| -4% | -$18.9K | ﹤0.01% | 1541 |
|
|
2019
Q2 | $666K | Buy |
169,735
+126,347
| +291% | +$496K | ﹤0.01% | 1381 |
|
|
2019
Q1 | $206K | Buy |
43,388
+28,750
| +196% | +$137K | ﹤0.01% | 1939 |
|
|
2018
Q4 | $34K | Buy |
14,638
+4,375
| +43% | +$10.2K | ﹤0.01% | 2018 |
|
|
2018
Q3 | $64K | Buy |
10,263
+4,000
| +64% | +$24.9K | ﹤0.01% | 2078 |
|
|
2018
Q2 | $43K | Buy |
6,263
+2,513
| +67% | +$17.3K | ﹤0.01% | 2050 |
|
|
2018
Q1 | $32K | Buy |
+3,750
| New | +$32K | ﹤0.01% | 2014 |
|